Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion type Assertion NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_head.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion wasGeneratedBy ECO_0000203 NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_provenance.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion wasDerivedFrom befree-20150227 NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_provenance.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion SIO_000772 17264302 NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_provenance.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion evidence source_evidence_literature NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_provenance.
- NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_assertion description "[In all 3 treatment phases, a glucuronosyltransferase polymorphism predicted hyperbilirubinemia (P = .017, P < .001, and P < .001) and methotrexate clearance (P = .028), which was also independently associated with hyperbilirubinemia (P = .026).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609794.RA6v0jrcT9Hf5w2dG3Gu-DF-jcBas70CxZBhNGgh81IKE130_provenance.